Kurzfassung

Randomized, double-blind, multicenter two-stage adaptive phase 3 study of intravenous administration of REOLYSIN (Reovirus type 3 dearing) in combination with Paclitaxel and Carboplatin versus the chemotherapy alone in patients with metastatic or recurrent squamous cell carcinoma of the head and neck who have progressed on or after prior platinum- based chemotherapy